Journey Medical Corporation ( DERM) - Key Metrics
DERM Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.66 | -$0.05 | -$0.26 | -$0.26 |
| 2025Q3 | $0.71 | -$0.09 | -$0.10 | -$0.10 |
| 2025Q2 | $0.64 | -$0.16 | -$0.04 | -$0.04 |
| 2025Q1 | $0.58 | -$0.18 | -$0.13 | -$0.13 |
DERM Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -37.87 |
| 2025Q3 | ? | -19.19 |
| 2025Q2 | ? | -11.01 |
| 2025Q1 | ? | -8.19 |
DERM Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 2.27% | ? |
| 2025Q4 | -3.37% | ? |
| 2025Q3 | -1.34% | ? |
| 2025Q2 | -0.56% | ? |
| 2025Q1 | -2.12% | ? |
DERM
Price: $6.06
52 week price:
Earnings Per Share: -0.37 USD
Exchange: NCM
Sector: Healthcare
Industry: Drug Manufacturers - Specialty & Generic
Country: United States
Volume: 25200
Ebitda: -176.2 millionMarket Capitalization: 168.9 million